Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Top Cited Papers
- 24 June 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (15) , 5025-5037
- https://doi.org/10.1021/jm050261p
Abstract
Efforts to further elucidate structure−activity relationships (SAR) within our previously disclosed series of β-quaternary amino acid linked l-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines. Despite poor systemic exposure, vinyl-substituted compounds showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models. Oxygenated putative metabolites were prepared and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats. Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compound BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clinical trials for treatment of type 2 diabetes.Keywords
This publication has 43 references indexed in Scilit:
- Substituted piperazines as novel dipeptidyl peptidase IV inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Glucagon-like Peptide-1: The Basis of a New Class of Treatment for Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2003
- The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed β-propeller foldBiochemical and Biophysical Research Communications, 2003
- Structural Requirements for Catalysis, Expression, and Dimerization in the CD26/DPIV Gene FamilyBiochemistry, 2002
- Application of the Ester Enolate Claisen Rearrangement in the Synthesis of Amino Acids Containing Quaternary Carbon CentersThe Journal of Organic Chemistry, 1996
- Novel Synthesis of 3-Fluoro-1-Aminoadamantane and Some of its DerivativesSynthetic Communications, 1988
- STUDIES ON RACEMIZATION DURING COUPLINGS USING A SERIES OF MODEL TRIPEPTIDES INVOLVING ACTIVATED RESIDUES WITH UNFUNCTIONALIZED SIDE CHAINSInternational Journal of Peptide and Protein Research, 1981